(19)
(11) EP 4 824 066 A1

(12)

(43) Date of publication:
21.10.2026 Bulletin 2026/43

(21) Application number: 24837496.9

(22) Date of filing: 12.12.2024
(51) International Patent Classification (IPC): 
C07D 487/04(2006.01)
A61P 19/02(2006.01)
A61P 25/14(2006.01)
A61P 37/06(2006.01)
C07D 471/04(2006.01)
A61P 19/06(2006.01)
A61P 25/28(2006.01)
A61K 31/437(2006.01)
(52) Cooperative Patent Classification (CPC):
C07D 471/04; C07D 487/04; A61K 31/437; A61P 19/02; A61P 25/14; A61P 25/28; A61P 37/06; A61P 19/06
(86) International application number:
PCT/US2024/059705
(87) International publication number:
WO 2025/128781 (19.06.2025 Gazette 2025/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 14.12.2023 US 202363610235 P

(71) Applicant: Merck Sharp & Dohme LLC
Rahway, New Jersey 07065 (US)

(72) Inventors:
  • BRILL, Zachary G.
    Rahway, New Jersey 07065 (US)
  • HAYES, Donna A. A. W.
    Rahway, New Jersey 07065 (US)
  • LAM, Tom M.
    Rahway, New Jersey 07065 (US)
  • MCCLYMONT, Kyle S.
    Rahway, New Jersey 07065 (US)
  • MATSUURA, Bryan S.
    Rahway, New Jersey 07065 (US)
  • MERCHANT, Rohan Rajiv
    Rahway, New Jersey 07065 (US)
  • NAIR, Anilkumar G.
    Rahway, New Jersey 07065 (US)
  • QI, Ning
    Rahway, New Jersey 07065 (US)

(74) Representative: Merck Sharp & Dohme LLC 
120 Moorgate
London EC2M 6UR
London EC2M 6UR (GB)

   


(54) AZAINDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF NOD-LIKE RECEPTOR PROTEIN 3